Filing Details
- Accession Number:
- 0000950170-24-066088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-29 17:27:22
- Reporting Period:
- 2024-05-28
- Accepted Time:
- 2024-05-29 17:27:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885978 | U S Physical Therapy Inc | USPH | Services-Health Services (8000) | 760364866 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1270356 | J Christopher Reading | 1300 W Sam Houston Pkwy S Suite 300 Houston TX 77042 | Chairman Of The Board And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-05-28 | 1,100 | $102.13 | 99,738 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-05-29 | 1,000 | $100.13 | 98,738 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- For the transaction executed on May 28, 2024, the price reported ($102.13) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $102.00 to $102.26 per share, both inclusive. For the transaction executed on May 29, 2024, the price reported ($100.13) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $100.00 to $100.49 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- Includes 32,913 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 3,587 shares on each of July 1, 2024 and October 1, 2024; 3,588 shares on January 1, 2025; 2,887 shares on each April 1, 2025, July 1, 2025, and on October 1, 2025; 2,888 shares on January 1, 2026; 1,637 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 1,638 shares on January 1, 2027; and 1,012 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 1,017 shares on January 1, 2028, if he is an Officer of the Company on those dates.